Sarah Cannon Research Institute

Clinical research site in Jacksonville, Florida

As of July 2026, 1 paid clinical trial is recruiting at Sarah Cannon Research Institute in Jacksonville, Florida. Active studies at this site focus on Progressive Metastatic Castrate Resistant Prostate Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Sarah Cannon Research Institute (1)

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

for Progressive Metastatic Castrate Resistant Prostate Cancer

7 locations incl. Denver

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18+

Code: NCT07206056·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Explore more

Paid clinical trials in Jacksonville, FL · Florida clinical trials

Sarah Cannon Research Institute

Recruiting clinical trials at Sarah Cannon Research Institute (1)

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

More research sites in Jacksonville

Explore more